Providing a diverse range of perspectives from bullish to bearish, 10 analysts have published ratings on Sage Therapeutics (NASDAQ:SAGE) in the last three months.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 2 | 6 | 2 | 0 |
Last 30D | 0 | 0 | 0 | 0 | 0 |
1M Ago | 0 | 2 | 3 | 0 | 0 |
2M Ago | 0 | 0 | 3 | 2 | 0 |
3M Ago | 0 | 0 | 0 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $12.2, a high estimate of $26.00, and a low estimate of $4.00. Highlighting a 33.7% decrease, the current average has fallen from the previous average price target of $18.40.
![bigjpg](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20241120/0-66e5ab67952e6ea42fc3d47b919a687d-0-5539c7032d910103197b61845142eb65.webp/bigjpg)
Diving into Analyst Ratings: An In-Depth Exploration
The standing of Sage Therapeutics...
Login or create a forever free account to read this news
Sign up/Log in